Sort
30,917 grants matching “tumor microenvironment”
Flow cytometer for high-parameter analyses
$595,774Ann M Haberman · Yale University · S10 · FY2019 · OD
VLA-4âtargeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy
$595,764Ravi Bhasker Patel · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
$595,749Carol Thiele-Galetto · Basic Sciences · Z01 · FY2007 · CA
Host and parasite determinants of Leishmania Viannia persistence in naturally infected human populations
$595,744Najib M. El-Sayed · Univ Of Maryland, College Park · R01 · FY2025 · AI
Engineering immunotherapeutic probiotics to mitigate irAE
$595,682Tal Danino · Columbia Univ New York Morningside · U01 · FY2021 · CA
Mechanisms Promoting Copper Dependent Cell Death in Cancer
$595,634Peter Tsvetkov · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Reprogramming the Tumor Immune Microenvironment with Chemokines to Potentiate Immune Oncology Treatments in Oral Cancer
$595,600J. Silvio Gutkind · University Of California, San Diego · R01 · FY2024 · DE
Elucidating the Immune Suppressive Mechanism of SIGLEC-15 in the Tumor Microenvironment
$595,576Jun Wang · New York University School Of Medicine · R01 · FY2023 · CA
An urinary drug disposing approach for treatment of bladder Cancer
$595,483Benedict Shek Hang Law · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Mouse models of Kras-mutant colorectal cancer
$595,434Kevin Michael Haigis · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Immune Impact on Cancer Chemoresistance
$595,421Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2019 · CA
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$595,395Kim Butts Pauly · Stanford University · R01 · FY2021 · CA
Mechanisms of Stromal Cell Activation by the Developing Tumor
$595,379John Niederhuber · Basic Sciences · Z01 · FY2007 · CA
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
$595,374Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell Lymphomas
$595,348Raul Rabadan · Columbia University Health Sciences · U01 · FY2022 · CA
Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut
$595,247Michael Lawrence Dougan · Massachusetts General Hospital · R01 · FY2023 · AI
Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut
$595,247Michael Lawrence Dougan · Massachusetts General Hospital · R01 · FY2024 · AI
Molecular Pathways Regulating Tissue-resident Memory T cells in the Gut
$595,247Michael Lawrence Dougan · Massachusetts General Hospital · R01 · FY2025 · AI
Matrix Organization and Dimensionality
$595,208Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE
The role of hexokinase 2 in liver fibrosis and NASH-induced HCC
$595,149Nissim Hay · University Of Illinois At Chicago · R01 · FY2025 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy
$595,122Lily Yang · Emory University · U01 · FY2017 · CA
Next generation biomolecule-retention expansion microscopy for diverse imaging applications
$595,080Yongxin Zhao · Carnegie-Mellon University · R01 · FY2025 · EB
Osteoporosis in HIV-infected Postmenopausal Women
$595,077Elizabeth J. Shane · Columbia University Health Sciences · R01 · FY2008 · AI
Novel Markers for Disease Outcome in Breast Cancer
$595,046Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Predictive and Diagnostic Radiomic Signatures in Non-Small Cell Lung Cancer (NSCLC) on Immunotherapy
$594,981Despina Kontos · University Of Pennsylvania · R01 · FY2022 · CA